Stock BLAC BELLEVUE LIFE SCIENCES ACQUISITION CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Bellevue Life Sciences Acquisition Corp.

Equities

BLAC

US0791741087

Real-time Estimate Cboe BZX
Other stock markets
 09:30:09 2024-05-21 am EDT 		5-day change 1st Jan Change
10.76 USD -0.32% Intraday chart for Bellevue Life Sciences Acquisition Corp. +0.75% +2.86%
May. 14 Bellevue Life Sciences Acquisition Corp. announced that it has received $0.14 million in funding CI
Apr. 17 Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Bellevue Life Sciences Acquisition Corp. Announces the Resignation of Hosun Euh as Member of the Board of Directors, Effective June 21, 2023
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022
Bellevue Life Sciences Acquisition Corp. Auditor Raises 'Going Concern' Doubt
Bellevue Life Sciences Acquisition Corp. has completed an IPO in the amount of $60 million.
Bellevue Life Sciences Acquisition Corp. has filed an IPO in the amount of $60 million.
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BLAC Stock
  4. News Bellevue Life Sciences Acquisition Corp.
  5. Other languages
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW